Latest current cash for BDR: $79K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Blonder Tongue Laboratories posts a current cash of $79K as of December 2022. That compares with $270K in the prior-year period — down 71.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Blonder Tongue Laboratories's current cash was $270K. The latest reading is $79K — a 71.2% year-over-year decrease (period ending December 2022). Use the history and growth charts on this page for a longer lookback.
Current Cash is one piece of Blonder Tongue Laboratories's financial statement story. At $79K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for BDR's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Blonder Tongue Laboratories's other metric pages and overview cover the third.
Judging Blonder Tongue Laboratories against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in current cash easier to interpret. Start with $79K here, then scan peer and history charts to see if the gap is persistent.